Speciality Medicines Limited has launched its Initial Public Offering (IPO) today, March 20, 2026, on the BSE SME platform. The company, based in Ahmedabad, is involved in the marketing and distribution of finished formulations of specialty pharmaceuticals, primarily used to treat complex chronic conditions such as oncology, immunology, and neurology.

Below are the comprehensive details of the Speciality Medicines IPO:

Key Dates and Timeline

IPO Structure and Pricing

Application Lot Size and Investment (Retail)

To apply for the Speciality Medicines IPO, retail investors must bid for a minimum of 2 lots.

Note: For HNI investors, the minimum application starts at 3 lots (3,000 shares), amounting to ₹3,72,000 at the upper price band.

Objectives of the Issue

The company intends to use the net proceeds from the fresh issue for the following purposes:

1. Setting up of a Research and Development (R&D) Center: ~43.72% of proceeds.
2. To Meet Working Capital Requirements: ~27.59% of proceeds.
3. General Corporate Purposes: ~12.63% of proceeds.
4. Product Registration and Development in International Markets: ~10.31% of proceeds.
5. Funding for Marketing and Promotional Activities: ~5.72% of proceeds.

Key Financial Metrics (Annualized)

Based on annualized data for the period ended October 31, 2025:

Lead Manager and Registrar